MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Casas-González, P.
Right arrow Articles by García-Sáinz, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Casas-González, P.
Right arrow Articles by García-Sáinz, J. A.

Vol. 57, Issue 5, 1027-1033, May 2000

Lysophosphatidic Acid Modulates alpha 1b-Adrenoceptor Phosphorylation and Function: Roles of Gi and Phosphoinositide 3-Kinase

Patricia Casas-González, José Vázquez-Prado, and J. Adolfo García-Sáinz

Departamento de Biología Celular, Instituto de Fisiología Celular, Universidad Nacional Autónoma de México, México City, México

The effect of lysophosphatidic acid on the phosphorylation and function of alpha 1b-adrenoceptors transfected into rat-1 fibroblasts was studied. This phospholipid mitogen increased in a concentration-dependent fashion (EC50 ~50 nM) the phosphorylation of these adrenoceptors. Lysophosphatidic acid-induced alpha 1b-adrenoceptor phosphorylation was relatively rapid (t1/2 ~1 min), intense (2.5-fold), and sustained for at least 60 min. The effect of lysophosphatidic acid was blocked by pretreatment with pertussis toxin. The alpha 1b-adrenoceptor phosphorylation induced by lysophosphatidic acid was not blocked by genistein, a tyrosine kinase inhibitor, but it was inhibited by inhibitors of protein kinase C (bisindolylmaleimide I, staurosporine, and Ro 31-8220) and phosphoinositide 3-kinase (wortmannin and LY 294002). The ability of norepinephrine to increase cytosol calcium concentration was markedly decreased in cells previously challenged with lysophosphatidic acid. Norepinephrine-induced [35S]GTPgamma S binding in membrane preparations was used as an index of the functional coupling of the alpha 1b-adrenoceptors and G proteins. Norepinephrine-stimulated [35S]GTPgamma S binding was markedly decreased in membranes from cells pretreated with lysophosphatidic acid. This effect of lysophosphatidic acid was blocked by pretreatment with wortmannin or staurosporine. Our data indicate that: 1) activation of lysophosphatidic acid receptors induce phosphorylation of alpha 1b-adrenoceptors; 2) this effect is mediated through pertussis toxin-sensitive G proteins, phosphatidylinositol 3-kinase, and protein kinase C; and 3) the phosphorylation of alpha 1b-adrenoceptors induced by the lipid mitogen is associated to adrenoceptor desensitization.


Copyright © 2000 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
Mol. Endocrinol.Home page
T. Molina-Munoz, M. T. Romero-Avila, and J. A. Garcia-Sainz
Insulin-Like Growth Factor-I Induces {alpha}1B-Adrenergic Receptor Phosphorylation through Gss{gamma} and Epidermal Growth Factor Receptor Transactivation
Mol. Endocrinol., November 1, 2006; 20(11): 2773 - 2783.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
A. García-Caballero, J. A. Olivares-Reyes, K. J. Catt, and J. A. García-Saínz
Angiotensin AT1 Receptor Phosphorylation and Desensitization in a Hepatic Cell Line. Roles of Protein Kinase C and Phosphoinositide 3-Kinase
Mol. Pharmacol., March 1, 2001; 59(3): 576 - 585.
[Abstract] [Full Text]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2000 by the American Society for Pharmacology and Experimental Therapeutics